Life Saving Drugs Program resources – Hereditary tyrosinaemia type 1

A collection of resources for health professionals to help people with hereditary tyrosinaemia type 1 access nitisinone (Orfadin® and Nityr™) under the Life Saving Drugs Program.

Collection description

This collection contains guidelines, forms and documents related to accessing nitisinone under the Life Saving Drugs Program. Click to view the product information for each brand on the Therapeutic Goods Administration website:



Medicines review documents

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Date last updated:
Health sector

Help us improve

If you would like a response please use the enquiries form instead.